Arzneiverordnungen 2024 im Überblick
- 24 February 2026
- book chapter
- Published by Springer Nature
- p. 3-25
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Updated analysis of the prescription and evaluation of protein kinase inhibitors for oncology in GermanyNaunyn-Schmiedeberg's Archives of Pharmacology, 2024
- Critical analysis of the prescription and evaluation of protein kinase inhibitors for oncology in GermanyNaunyn-Schmiedeberg's Archives of Pharmacology, 2023
- The Timing of Cancer Drug Approvals in the United States and EuropeJAMA Network Open, 2022
- Hochpreisigkeit bei Onkologika2021
- Arzneimittel-Kompass 20212021
- The Language of Biosimilars: Clarification, Definitions, and Regulatory AspectsDrugs, 2017
- How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European CountriesApplied Health Economics and Health Policy, 2017
- The Rising Cost of Prescription Drugs: Causes and SolutionsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2016
- Pharmakologie und Toxikologie2016
- The burden of rheumatoid arthritis and access to treatment: uptake of new therapiesThe European Journal of Health Economics, 2007